Jci_page_head_homepage_01 Jci_page_head_homepage_02
Bing Ma, Min-Jong Kang, Chun Geun Lee, Svetlana Chapoval, Wei Liu, Qingsheng Chen, Anthony J. Coyle, José M. Lora, Dominic Picarella, Robert J. Homer, Jack A. Elias
Published in Volume 115, Issue 12
J Clin Invest. 2005; 115(12):3460–3472 doi:10.1172/JCI24858
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Jci0524858
Figure 9

Role of CCR5 in IFN-γ regulation of cell death pathways. (A, D, and F) Tg and Tg+ mice were placed on dox water and treated with anti-CCR5 or control Ig. (B, C, E, and G) CCR5+/+ and CCR5–/– Tg and Tg+ mice were treated with dox water for 4 weeks. mRNA was evaluated by RT-PCR (A and B) and real-time RT-PCR (C). BAL TNF levels were evaluated by ELISA (D and E). (F) Caspase-3, -8, and -9, Bid, and truncated Bid (tBid) were evaluated by Western blot analysis. (G) Caspase bioactivity was evaluated. Each evaluation in A, B, and F is representative of a minimum of 4 similar experiments. The values in the remaining panels represent the mean ± SEM of evaluations in a minimum of 5 animals. *P < 0.05.